Healthcare

Vitrafy Life Sciences Limited (ASX:VFY) saw its shares move higher during the morning session on 2 June 2026, rising 3.38% to AUD 2.75. The upward movement followed the company’s announcement of a new partnership with Vitalant Innovation Center in the United States, aimed at …

Epiminder Ltd (ASX:EPI) attracted investor attention on 1 June 2026 after announcing a key milestone in its DETECT clinical study, with shares rising 6.33% to AUD 0.42 during the session. While the stock remains down 67.94% over the past year, the latest update appeared …

Paradigm Biopharmaceuticals Ltd (ASX:PAR) has announced the successful completion of its Share Purchase Plan (SPP), with existing shareholders providing support well above the company's original fundraising target. The plan generated approximately A$7.375 million, significantly exceeding the initial objective of A$2 million and further strengthening …

Optiscan Imaging Ltd (ASX:OIL) has announced that its collaboration with Mayo Clinic has reached an important two-year milestone, with both organisations continuing to advance the development of a digital endomicroscopic imaging system designed for use in robotic-assisted surgery. The update highlighted the completion of …

Pro Medicus Limited (ASX:PME) attracted significant investor attention on 1 June 2026 after announcing two major contract wins with United States healthcare providers. The company secured a five-year contract renewal valued at A$28 million with Allegheny Health Network (AHN) and a separate seven-year agreement …

ReNerve Ltd (ASX:RNV) shares traded 3.75% higher at AUD 0.083 during the afternoon session on 1 June 2026 after the company announced a new commercial distributionPartnershipaimed at expanding the reach of its nerve repair products across key Asian healthcare markets. Despite today's gain, the …

Singular Health Group Ltd (ASX:SHG) recorded a modest upward move on 1 June, with shares rising 9.52% to AUD 0.23 during the session. The gain came alongside a corporate update confirming the exercise of unlisted options and the issuance of new ordinary shares.